SCHEMBL24487481

SCHEMBL24487481

C=Cc1cccc(-c2ccc(-c3ccc(CC)cc3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.51
TP53 P04637 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
BCL2 P10415 1/20 0.42
TAAR1 Q96RJ0 4/20 0.37
TRIM24 O15164 1/20 0.37
TRIM33 Q9UPN9 1/20 0.37
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
TGFBR1 P36897 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
HDAC8 Q9BY41 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4515452 1.00 PTGS2 (0.51) PTGS2TP53TDP1BCL2TAAR1
SCHEMBL29434177 1.00 PTGS2 (0.51) PTGS2TP53TDP1BCL2TAAR1
SCHEMBL29434194 0.87 BCL2 (0.47) PTGS2TP53TDP1BCL2TGFBR1
SCHEMBL4517268 0.87 BCL2 (0.47) PTGS2TP53TDP1BCL2TGFBR1
SCHEMBL29434161 0.86 PTGS2 (0.49) PTGS2TP53TDP1TAAR1KCNH2
SCHEMBL5034588 0.86 PTGS2 (0.49) PTGS2TP53TDP1TAAR1KCNH2
SCHEMBL595061 0.84 PTGS2 (0.59) PTGS2TP53TDP1TRIM24TRIM33
SCHEMBL4508221 0.82 BCL2 (0.54) PTGS2TP53TDP1BCL2ALDH1A1
SCHEMBL5735233 0.82 TRIM24 (0.56) PTGS2TDP1BCL2TRIM24TRIM33
SCHEMBL8436350 0.81 HSD11B1 (0.48) PTGS2TP53ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4008330-A1 COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-06-08 EP disclosed